StockNews.com Begins Coverage on Spectrum Pharmaceuticals (NASDAQ:SPPI)
StockNews.com began coverage on shares of Spectrum Pharmaceuticals (NASDAQ:SPPI – Free Report) in a research report sent to investors on Friday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, Jefferies Financial Group cut Spectrum Pharmaceuticals from a buy rating to a hold rating in a research report on Monday, May […]